MedTrace Logo

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device

NCT04001426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2021-11-04

No results posted yet for this study

Summary

The purpose of this feasibility clinical investigation is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.

Conditions

  • Urinary Bladder, Overactive

Interventions

DEVICE

The FemPulse System

Non-invasive monitoring during activation of the FemPulse System

Sponsors & Collaborators

  • FemPulse Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-04
Primary Completion
2019-12-31
Completion
2019-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04001426 on ClinicalTrials.gov